Safety profile of belzutifan monotherapy in patients with renal cell carcinoma: A pooled analysis of 4 clinical trials

被引：3

作者：

Choueiri, Toni K. ^{[1
]}

Ghatalia, Pooja ^{[2
]}

de Velasco, Guillermo ^{[3
]}

Albiges, Laurence ^{[4
]}

Burotto, Mauricio ^{[5
]}

Suarez, Cristina ^{[6
]}

Brugarolas, James ^{[7
]}

Iacovelli, Roberto ^{[8
]}

Jalkanen, Katriina ^{[9
]}

Lam, Elaine T. ^{[10
]}

Srinivasan, Ramaprasad ^{[11
]}

Merchan, Jaime ^{[12
]}

Agarwal, Neeraj ^{[13
]}

Iversen, Ane B. ^{[14
]}

Rini, Brian ^{[15
]}

Bauer, Todd M. ^{[16
]}

Gurney, Howard ^{[17
]}

Iliopoulos, Othon ^{[18
,19
]}

Lin, Jianxin ^{[20
]}

Starkopf, Liis ^{[20
]}

Donica, Margarita ^{[20
]}

Gumieniak, Olga ^{[20
]}

Vickery, Donna ^{[20
]}

Liu, Yanfang ^{[20
]}

Perini, Rodolfo F. ^{[20
]}

Powles, Thomas ^{[21
]}

Jonasch, Eric ^{[22
]}

机构：

[1] Dana Farber Canc Inst, Boston, MA USA

[2] Fox Chase Canc Ctr, Philadelphia, PA USA

[3] Univ Hosp 12 Octubre, Madrid, Spain

[4] Inst Gustave Roussy, Med Oncol Dept, Villejuif, France

[5] Bradford Hill Clin Res Ctr, Santiago, Chile

[6] Hosp Univ Vall Dhebron, Vall dHebron Inst Oncol VHIO, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain

[7] Univ Texas Southwestern Med Ctr Dallas, Internal Med Hematol Oncol, Dallas, TX USA

[8] Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy

[9] HUS Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland

[10] Univ Colorado Anschutz Med Campus, Univ Colorado Canc Ctr, Aurora, CO USA

[11] NCI, Ctr Canc Res, Bethesda, MD USA

[12] Univ Miami Hosp & Clin, Sylvester Canc Ctr, Canc Res Serv, Oncol, Miami, FL USA

[13] Huntsman Canc Inst, Clin Translat Canc Res Genitourinary Oncol Progra, Salt Lake City, UT USA

[14] Aarhus Univ Hosp, Aarhus, Denmark

[15] Vanderbilt Ingram Canc Ctr, Nashville, OH USA

[16] Greco Hainsworth Ctr Res Tennessee Oncol PLLC, Nashville, TN USA

[17] Macquarie Univ, Oncol, Sydney, NSW, Australia

[18] Massachusetts Gen Hosp, Canc Ctr, Boston, MA USA

[19] Harvard Med Sch, Boston, MA USA

[20] Merck & Co Inc, Rahway, NJ USA

[21] Barts Hlth NHS Trust, St Bartholomews Hosp, London, England

[22] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

来源：

ONCOLOGIST | 2024年 / 29卷

关键词：

Belzutifan; HIF-2a; renal cell carcinoma;

D O I：

10.1093/oncolo/oyae181.004

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 50 条

[41] Safety of Adjuvant Pembrolizumab (pembro) in a Pooled Analysis of Phase 3 Clinical Trials in Melanoma, Non-Small Cell Lung Cancer (NSCLC), and Renal Cell Carcinoma
Luke, Jason J.
Long, Georgina V.
Robert, Caroline
Carlino, Matteo S.
Choueiri, Toni K.
Haas, Naomi B.
O'Brien, Mary
Paz-Ares, Luis
Peters, Solange
Powles, Thomas
Leiby, Melanie A.
Lin, Jianxin
Zhao, Yujie
Krepler, Clemens
Perini, Rodolfo
Pietanza, M. Catherine
Samkari, Ayman
Gruber, Todd
Ibrahim, Nageatte
Eggermont, Alexander M. M.
ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S187 - S187
[42] Characterization of patients with poor risk metastatic renal cell carcinoma (mRCC): results from a pooled clinical trials database
Hamieh, Lana
Mckay, Rana
Lin, Xun
Simantov, Ronit
Choueiri, Toni
BJU INTERNATIONAL, 2016, 118 : 10 - 10
[43] Efficacy of escitalopram monotherapy in the treatment of major depressive disorder A pooled analysis of 4 Chinese clinical trials
Li, Guanjun
Shen, Yifeng
Luo, Jianfeng
Li, Huafang
MEDICINE, 2017, 96 (39)
[44] LONG-TERM SAFETY OF PIRFENIDONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: POOLED ANALYSIS OF 4 CLINICAL TRIALS
Noble, P. W.
Albera, C.
Lancaster, L.
Hormel, P.
Hulter, H.
Costabel, U.
THORAX, 2016, 71 : A175 - A176
[45] RETRACTED: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment (Retracted Article)
Oya, Mototsugu
Kaneko, Shuichi
Imai, Tsuneo
Tsujino, Toshiaki
Sunaya, Toshiyuki
Okayama, Yutaka
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (06) : 761 - 772
[46] Secukinumab Demonstrates a Consistent Safety Profile in Patients with Psoriasis, Psoriatic Arthritis and Axial Spondyloarthritis: Updated Pooled Safety Analysis from Clinical Trials
Deodhar, Atul
McInnes, Iain
Baraliakos, Xenofon
Gottlieb, Alice B.
Kiltz, Uta
Schreiber, Stefan
Sahoo, Braja Gopal
Bao, Weibin
Richards, Hanno
Pricop, Luminita
Gaillez, Corine
Dong, Victor
Mease, Philip J.
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2830 - 2831
[47] The safety profile of panitumumab monotherapy in patients with metastatic colorectal cancer (MCRC) across 10 clinical trials
Knoop, Teresa
ONCOLOGY NURSING FORUM, 2008, 35 (03) : 491 - 491
[48] Trabectedin phase II clinical trials: Pooled analysis of safety in patients with solid tumors
Cioffi, A.
LeCesne, A.
Blay, J.
Delaloge, S.
Yovine, A.
Maki, R.
Nieto, A.
Jiao, J. J.
Demetri, G. D.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[49] Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma
Manley, Brandon John
Zabor, Emily C.
Casuscelli, Jozefina
Tennenbaum, Daniel M.
Redzematovic, Almedina
Becerra, Maria F.
Benfante, Nicole
Sato, Yusuke
Morikawa, Teppei
Kume, Haruki
Fukayama, Masashi
Homma, Yukio
Ogawa, Seishi
Arcila, Maria E.
Voss, Martin H.
Feldman, Darren R.
Coleman, Jonathan A.
Reuter, Victor E.
Motzer, Robert J.
Russo, Paul
Hsieh, James J.
Hakimi, A. Ari
EUROPEAN UROLOGY FOCUS, 2017, 3 (4-5): : 421 - 427
[50] Characterization of Patients With Poor-Risk Metastatic Renal-Cell Carcinoma: Results From a Pooled Clinical Trials Database
Hamieh, Lana
Mckay, Rana R.
Lin, Xun
Simantov, Ronit
Choueiri, Toni K.
CLINICAL GENITOURINARY CANCER, 2018, 16 (01) : 13 - +

← 1 2 3 4 5 →